Human Papillomavirus Oncogenic mRNA Testing for Cervical Cancer Screening-Reference-Cited by-同舟云学术

Human Papillomavirus Oncogenic mRNA Testing for Cervical Cancer Screening

Published:2015-09-01 Issue:3 Volume:144 Page:473-483
ISSN:1943-7722
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:

Author:

Reid Jennifer L.¹,Wright Thomas C.²,Stoler Mark H.³,Cuzick Jack⁴,Castle Philip E.⁵,Dockter Janel¹,Getman Damon¹,Giachetti Cristina¹

Affiliation:

1. From Hologic, Incorporated, San Diego, CA;

2. Department of Pathology, Columbia University School of Medicine, New York, NY;

3. University of Virginia Health System, Charlottesville;

4. Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK; and

5. Global Cancer Initiative, Chestertown, MD.

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/144/3/473/25000172/ajcpath144-0473.pdf

Reference48 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer;Sasieni;Br J Cancer,1996

3. International incidence rates of invasive cervical cancer after introduction of cytological screening;Gustafsson;Cancer Causes Control,1997

4. US Cancer Statistics Working Group . United States Cancer Statistics: 2004 Incidence and Mortality. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2007. www.cdc.gov/cancer/npcr/npcrpdfs/US_Cancer_Statistics_2004_Incidence_and_Mortaliy.pdf. Accessed October 13, 2014.

5. New developments in cervical cancer screening and prevention. Geneva, Switzerland, June 17–19, 1996. Workshop;Franco;Cancer Epidemiol Biomarkers Prev,1996

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel method for colposcopic shunting in HPV-positive women: Quantitative detection of HPV E7 oncoprotein;Heliyon;2024-02

2. Do women with high-risk HPV E6/E7 mRNA test positivity and NILM cytology need colposcopy?;Infectious Agents and Cancer;2023-09-29

3. Modern approaches to cervical cancer screening (a review);Pathologia;2023-04-28

4. Correlation of immediate prevalence of cervical precancers and cancers with HPV genotype and age in women with ASC-US/hrHPV+: a retrospective analysis of 2292 cases;Journal of Clinical Pathology;2023-01-18

5. Risk stratification for cervical precancer and cancer by DH3‐HPV partial genotyping and cytology in women attending cervical screening: A retrospective cohort study;Journal of Medical Virology;2023-01-13